Skip to main content

BUX · BioMark Diagnostics Inc. · Financials

0.4500 CAD +0.0000 (+0.00%) At close · Nov 4 Intraday price with Plus
Market Cap
47.92M CAD
Shares
106.48M

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Revenue
154.22K -5.5%
FY2025 Revenue FY2024–FY2025
Net Income
-1.93M -35%
FY2025 Net Income FY2024–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2025 FY2024
CAD 154.22K 163.22K
CAD -1.93M -1.43M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.